Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer
The presence of tumor infiltrating lymphocytes (TILs) is associated with a longer overall survival in advanced stage epithelial ovarian cancer. Despite the prognostic impact of TILs, response to checkpoint-inhibitors and antigen-specific active immunotherapy is limited in ovarian cancer. The goal of...
Main Authors: | Thaïs Baert, Ann Vankerckhoven, Matteo Riva, Anaïs Van Hoylandt, Gitte Thirion, Gerhardt Holger, Thomas Mathivet, Ignace Vergote, An Coosemans |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.01273/full |
Similar Items
-
Ovarian cancer and the immune system
by: Thaïs Baert, et al.
Published: (2017-02-01) -
Opposite Macrophage Polarization in Different Subsets of Ovarian Cancer: Observation from a Pilot Study
by: Ann Vankerckhoven, et al.
Published: (2020-01-01) -
Neo-Adjuvant Chemotherapy Reduces, and Surgery Increases Immunosuppression in First-Line Treatment for Ovarian Cancer
by: Christine De Bruyn, et al.
Published: (2021-11-01) -
Effect of Particle Carriers for Intraperitoneal Drug Delivery on the Course of Ovarian Cancer and Its Immune Microenvironment in a Mouse Model
by: Roxanne Wouters, et al.
Published: (2022-03-01) -
Drug Repurposing for Targeting Myeloid-Derived Suppressor-Cell-Generated Immunosuppression in Ovarian Cancer: A Literature Review of Potential Candidates
by: Yani Berckmans, et al.
Published: (2023-06-01)